VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (3)
14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival.
DO BIOMARKERS PREDICT RESPONSE TO A PEDIATRIC CHRONIC PAIN SYMPTOM MANAGEMENT PROGRAM?
Exploring situational awareness in diagnostic errors in primary care.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
DO BIOMARKERS PREDICT RESPONSE TO A PEDIATRIC CHRONIC PAIN SYMPTOM MANAGEMENT PROGRAM?
Biography
contributor
Principal Investigator
Overview
sponsor award id
R01NR016786
Time
start date
2018-06-06
end date
2024-03-31